Health
MS lifeline as drug that can slow disease listed – Chinchilla News
Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.
Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…
-
Noosa News17 hours agoFearless tradie armed with hunting knife confronts teenage intruder at Mackay home
-
General20 hours agoContact tracing underway in Queensland as health authorities brace for further measles cases
-
Noosa News15 hours agoState school teachers rally outside Parliament
-
General14 hours agoLabor backbencher Dave Kelly hopes WA government’s Dion Barber compensation appeal fails